Wei Jiang founded medicine 3D printing startup Craft Health as a Pharmacy student. I love it when practitioners and people from other backgrounds establish 3D printing companies. It often leads to user-driven companies that cater well to those trying to use additive manufacturing. In this episode of the 3DPOD, we follow Craft Health’s journey from inception to funding and the release of the firm’s 3D printer for pharmaceuticals. We discuss release kinetics, approvals, drug delivery, compounding pharmacies, dosage forms, polypills, delayed release, nutrition, dementia care, and much more. 3D printing for pharmaceuticals has significant potential, and not enough people are paying attention.
Podcast: Play in new window | Download
Podcast (podcast-audio): Play in new window | Download
Subscribe to Our Email Newsletter
Stay up-to-date on all the latest news from the 3D printing industry and receive information and offers from third party vendors.
Print Services
Upload your 3D Models and get them printed quickly and efficiently.
You May Also Like
Interview with Interspectral’s Isabelle Hachette on Predicting Defects Before They Happen
Interspectral is a Swedish company that enables data visualization and intelligence through AI. The firm has Quality Assurance and Process Monitoring software for additive, called AM Explorer, which helps companies...
3D Printing Financials: Invisalign Demand Keeps Align’s 2025 Growth on Track
Align Technology‘s (Nasdaq: ALGN) third quarter showed a company tightening its operations while keeping growth steady. Demand for its Invisalign clear aligners continued to drive growth, led by rising demand among...
Bioprinting, Organoids, & Organs-on-a-Chip Work Together to Battle Cancer
Researchers at the Oregon Health & Science University (OHSU) Knight Cancer Institute are using a combination of bioprinted organoids, organs-on-a-chip, and computational medicine to battle cancer. The team is specifically...
CustoMED Gets $6 Million for AI 3D Printed Orthopedics — But Can It Deliver on Such a Big Vision?
Israeli startup CustoMED has gotten $6 million to make patient-specific orthopedic devices a reality using AI. The seed round took in capital from the Israel Innovation Authority, Varana Capital, Flag...



























